x
|
QUARTERLY REPORT PURSUANT TO
SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF
1934
|
o
|
TRANSITION
REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF
1934
|
Delaware
|
13-3115216
|
|
(State
of incorporation)
|
(IRS
Employer Identification Number)
|
701
Koehler Avenue, Suite 7, Ronkonkoma, New York
|
11779
|
|
(Address
of principal executive offices)
|
(Zip
Code)
|
Large
accelerated filer o
|
Accelerated
filer
o
|
|
Non-Accelerated
filer o (Do not check if
a smaller reporting company)
|
Smaller
reporting company x
|
Class
|
Outstanding at December 8,
2008
|
|
Common
Stock, $0.01 par value per share
|
5,415,971
|
PART I -
|
FINANCIAL
INFORMATION
|
Financial
Statements:
|
|
·
|
Our
ability to obtain fabrics and components from key suppliers such as DuPont
and other manufacturers at competitive prices or prices that vary from
quarter to quarter;
|
|
·
|
Risks
associated with our international manufacturing and start up sales
operations;
|
|
·
|
Potential
fluctuations in foreign currency exchange
rates;
|
|
·
|
Our
ability to respond to rapid technological
change;
|
|
·
|
Our
ability to identify and complete acquisitions or future
expansion;
|
|
·
|
Our
ability to manage our growth;
|
|
·
|
Our
ability to recruit and retain skilled employees, including our senior
management;
|
|
·
|
Our
ability to accurately estimate customer
demand;
|
|
·
|
Competition
from other companies, including some with much greater
resources;
|
|
·
|
Risks
associated with sales to foreign
buyers;
|
|
·
|
Restrictions
on our financial and operating flexibility as a result of covenants in our
credit facilitates;
|
|
·
|
Our
ability to obtain additional funding to expand or operate our business as
planned;
|
|
·
|
The
impact of a decline in federal funding for preparations for terrorist
incidents;
|
|
·
|
The
impact of potential product liability
claims;
|
|
·
|
Liabilities
under environmental laws and
regulations;
|
|
·
|
Fluctuations
in the price of our common stock;
|
|
·
|
Variations
in our quarterly results of
operations;
|
|
·
|
The
cost of compliance with the Sarbanes-Oxley Act of 2002 and rules and
regulations relating to corporate governance and public
disclosure;
|
|
·
|
The
significant influence of our directors and executive officer on our
company and on matters subject to a vote of our
stockholders;
|
|
·
|
The
limited liquidity of our common
stock;
|
|
·
|
The
other factors referenced in this 10-Q, including, without limitation, in
the sections entitled “Management’s Discussion and Analysis of Financial
Condition and Results of Operations,” and
“Business.”
|
ASSETS
|
October
31, 2008
(Unaudited)
|
January
31,
2008
|
||||||
Current
assets:
|
||||||||
Cash
|
$ | 2,132,618 | $ | 3,427,672 | ||||
Accounts
receivable, net of allowance for doubtful accounts of $36,000
at October 31, 2008 and $45,000 at January 31,
2008
|
16,505,775 | 14,927,666 | ||||||
Inventories,
net of reserves of $493,000 at October 31, 2008 and
$607,000 at January 31, 2008
|
55,031,523 | 48,116,173 | ||||||
Deferred
income taxes
|
2,134,744 | 1,969,713 | ||||||
Other
current assets
|
4,293,714 | 1,828,210 | ||||||
Total
current assets
|
80,098,374 | 70,269,434 | ||||||
Property
and equipment, net of accumulated depreciation of $8,626,928 at
October
31, 2008 and $7,054,914 at January 31, 2008
|
13,702,952 | 13,324,648 | ||||||
Goodwill
|
8,420,241 | 871,297 | ||||||
Other
assets
|
910,087 | 157,474 | ||||||
TOTAL
ASSETS
|
$ | 103,131,654 | $ | 84,622,853 | ||||
LIABILITIES
AND STOCKHOLDERS' EQUITY
|
||||||||
Current
liabilities:
|
||||||||
Accounts
payable
|
$ | 5,126,979 | $ | 3,312,696 | ||||
Accrued
expenses and other current liabilities
|
2,463,300 | 1,684,161 | ||||||
Total
current liabilities
|
7,590,279 | 4,996,857 | ||||||
Construction
loan
|
1,499,918 | 1,882,085 | ||||||
Borrowings
under revolving credit facility
|
25,517,466 | 8,871,000 | ||||||
Other
non current liabilities
|
108,100 | ----- | ||||||
Commitments
and contingencies
|
----- | ----- | ||||||
Stockholders'
equity:
|
||||||||
Preferred
stock, $.01 par; authorized 1,500,000 shares
|
||||||||
(none
issued)
|
||||||||
Common
stock, $.01 par; authorized 10,000,000 shares;
|
||||||||
issued
and outstanding 5,523,288 shares at October 31, 2008 and
January 31, 2008
|
55,233 | 55,233 | ||||||
Less
treasury stock, at cost, 107,317 shares at October 31, 2008 and
0 shares at January 31, 2008
|
(1,255,459 | ) | ----- | |||||
Additional
paid-in capital
|
49,438,501 | 49,211,961 | ||||||
Other
comprehensive loss
|
(3,354,991 | ) | (36,073 | ) | ||||
Retained
earnings (1)
|
23,532,607 | 19,641,790 | ||||||
Stockholders'
equity
|
68,415,891 | 68,872,911 | ||||||
TOTAL
LIABILITIES AND SHAREHOLDERS’ EQUITY
|
$ | 103,131,654 | $ | 84,622,853 |
THREE
MONTHS ENDED
|
NINE
MONTHS ENDED
|
|||||||||||||||
October
31,
|
October
31,
|
|||||||||||||||
2008
|
2007
|
2008
|
2007
|
|||||||||||||
Net
sales
|
$ | 25,159,948 | $ | 23,452,983 | $ | 80,005,141 | $ | 70,781,406 | ||||||||
Cost
of goods sold
|
17,989,076 | 17,748,865 | 57,994,805 | 54,593,816 | ||||||||||||
Gross
profit
|
7,170,872 | 5,704,118 | 22,010,336 | 16,187,590 | ||||||||||||
Operating
expenses
|
5,110,642 | 4,355,330 | 16,308,254 | 12,928,909 | ||||||||||||
Operating
profit
|
2,060,230 | 1,348,788 | 5,702,082 | 3,258,681 | ||||||||||||
Interest
and other income, net
|
44,270 | 51,249 | 130,159 | 176,387 | ||||||||||||
Interest
expense
|
(284,463 | ) | (94,344 | ) | (637,958 | ) | (205,470 | ) | ||||||||
Income
before income taxes
|
1,820,037 | 1,305,693 | 5,194,283 | 3,229,598 | ||||||||||||
Provision
for income taxes
|
446,876 | 375,536 | 1,303,466 | 936,543 | ||||||||||||
Net
income
|
$ | 1,373,161 | $ | 930,157 | $ | 3,890,817 | $ | 2,293,055 | ||||||||
Net
income per common share*:
|
||||||||||||||||
Basic
|
$ | 0.25 | $ | 0.17 | $ | 0.71 | $ | 0.42 | ||||||||
Diluted
|
$ | 0.25 | $ | 0.17 | $ | 0.71 | $ | 0.41 | ||||||||
Weighted
average common shares outstanding*:
|
||||||||||||||||
Basic
|
5,415,971 | 5,523,288 | 5,442,690 | 5,522,572 | ||||||||||||
Diluted
|
5,456,536 | 5,544,619 | 5,480,689 | 5,542,144 |
Common Stock
|
Additional
Paid-in
Capital
|
Treasury Stock
|
Retained
Earnings
|
Other
Comprehensive
Income (Loss)
|
Total
|
|||||||||||||||||||||||||||
Shares
|
Amount
|
Shares
|
Amount
|
|||||||||||||||||||||||||||||
Balance
February 1, 2008
|
5,523,288 | $ | 55,233 | $ | 49,211,961 | ----- | $ | ----- | $ | 19,641,790 | $ | (36,073 | ) | $ | 68,872,911 | |||||||||||||||||
Net
Income
|
----- | ----- | ----- | ----- | ----- | 3,890,817 | ----- | 3,890,817 | ||||||||||||||||||||||||
Stock
Repurchase Program
|
----- | ----- | ----- | 107,317 | (1,255,459 | ) | ----- | ----- | (1,255,459 | ) | ||||||||||||||||||||||
Other
Comprehensive Loss
|
----- | ----- | ----- | ----- | ----- | ----- | (3,318,918 | ) | (3,318,918 | ) | ||||||||||||||||||||||
Stock
Based Compensation Restricted Stock Plan
|
----- | ----- | 194,996 | ----- | ----- | ----- | ----- | 194,996 | ||||||||||||||||||||||||
Issuance
of Director Stock Options
|
----- | ----- | 31,544 | ----- | ----- | ----- | ----- | 31,544 | ||||||||||||||||||||||||
Balance
October 31, 2008
|
5,523,288 | $ | 55,233 | $ | 49,438,501 | 107,317 | $ | (1,255,459 | ) | $ | 23,532,607 | $ | (3,354,991 | ) | $ | 68,415,891 |
NINE
MONTHS ENDED
|
||||||||
October
31,
|
||||||||
2008
|
2007
|
|||||||
Cash
Flows from Operating Activities:
|
||||||||
Net
income
|
$ | 3,890,817 | $ | 2,293,055 | ||||
Adjustments
to reconcile net income to net cash used in operating
activities:
|
||||||||
Stock
based compensation
|
226,540 | 170,772 | ||||||
Reserve
for doubtful accounts
|
(9,000 | ) | (13,000 | ) | ||||
Reserve
for inventory obsolescence
|
(114,000 | ) | 289,601 | |||||
Depreciation
and amortization
|
1,231,285 | 816,441 | ||||||
Deferred
income tax
|
(165,032 | ) | (157,591 | ) | ||||
Changes
in operating assets and liabilities:
|
||||||||
(Increase)
decrease in accounts receivable
|
(369,967 | ) | 33,744 | |||||
(Increase)
in inventories
|
(3,492,428 | ) | (5,809,366 | ) | ||||
(Increase)
decrease in other assets
|
(2,183,085 | ) | 1,369,535 | |||||
(Decrease)
in accounts payable, accrued expenses
and
other liabilities
|
(74,850 | ) | (628,465 | ) | ||||
Net
cash used in operating activities
|
(1,059,720 | ) | (1,635,274 | ) | ||||
Cash
Flows from Investing Activities:
|
||||||||
Purchases
of property and equipment
|
(1,588,511 | ) | (2,049,565 | ) | ||||
Acquisition
of Qualytextil, S.A.
|
(13,669,763 | ) | -------------- | |||||
Net
cash used in investing activities
|
(15,258,274 | ) | (2,049,565 | ) | ||||
Cash
Flows from Financing Activities:
|
||||||||
Purchases
of stock under stock repurchase program
|
(1,255,459 | ) | ----- | |||||
Proceeds
from exercise of stock option
|
----- | 6,690 | ||||||
Construction
loan proceeds
|
----- | 992,888 | ||||||
Net
borrowings under loan agreements
|
2,933,933 | 3,450,000 | ||||||
Borrowing
to fund Qualytextil Acquisition
|
13,344,466 | ------------ | ||||||
Net
cash provided by financing activities
|
15,022,940 | 4,449,578 | ||||||
Net (decrease)
increase in cash
|
(1,295,054 | ) | 764,739 | |||||
Cash
and cash equivalents at beginning of period
|
3,427,672 | 1,906,557 | ||||||
Cash
and cash equivalents at end of period
|
$ | 2,132,618 | $ | 2,671,296 |
|
The
condensed consolidated financial statements included herein have been
prepared by us, without audit, pursuant to the rules and regulations of
the Securities and Exchange Commission and reflect all adjustments
(consisting of only normal and recurring adjustments) which are, in the
opinion of management, necessary to present fairly the consolidated
financial information required therein. Certain information and
note disclosures normally included in financial statements prepared in
accordance with accounting principles generally accepted in the United
States of America (“GAAP”) have been condensed or omitted pursuant to such
rules and regulations. While we believe that the disclosures are adequate
to make the information presented not misleading, it is suggested that
these condensed consolidated financial statements be read in conjunction
with the consolidated financial statements and the notes thereto included
in our Annual Report on Form 10-K filed with the Securities and Exchange
Commission for the year ended January 31,
2008.
|
|
The
accompanying condensed consolidated financial statements include the
accounts of the Company and its wholly-owned subsidiaries. All
significant inter-company accounts and transactions have been
eliminated.
|
4.
|
Inventories:
|
Inventories
consist of the following:
|
October
31,
|
January
31,
|
||||||
2008
|
2008
|
|||||||
Raw
materials
|
$ | 26,658,682 | $ | 25,035,569 | ||||
Work-in-process
|
3,306,596 | 2,873,001 | ||||||
Finished
Goods
|
25,066,245 | 20,207,603 | ||||||
TOTAL
|
$ | 55,031,523 | $ | 48,116,173 | ||||
|
Inventories
include freight-in, materials, labor and overhead costs and are stated at
the lower of cost (on a first-in-first-out basis) or
market.
|
5.
|
Earnings Per
Share:
|
Three
Months Ended
|
Nine
Months Ended
|
|||||||||||||||
October
31,
|
October
31,
|
|||||||||||||||
2008
|
2007
|
2008
|
2007
|
|||||||||||||
Numerator
|
||||||||||||||||
Net
Income
|
$ | 1,373,161 | $ | 930,157 | $ | 3,890,817 | $ | 2,293,055 | ||||||||
Denominator
|
||||||||||||||||
Denominator for basic earnings per share
|
5,415,971 | 5,523,288 | 5,442,690 | 5,522,572 | ||||||||||||
(Weighted-average
shares which reflect 107,317 and 80,598 weighted average common shares in
the treasury as a result of the stock repurchase program for the three
months and the nine months ended October 31, 2008,
respectively)
|
||||||||||||||||
Effect
of dilutive securities from restricted stock plan and from dilutive effect
of stock options
|
40,565 | 21,331 | 37,999 | 19,572 | ||||||||||||
Denominator
for diluted earnings per share (adjusted weighted average
shares)
|
5,456,536 | 5,544,619 | 5,480,689 | 5,542,144 | ||||||||||||
Basic
earnings per share
|
$ | 0.25 | $ | 0.17 | $ | 0.71 | $ | 0.42 | ||||||||
Diluted
earnings per share
|
$ | 0.25 | $ | 0.17 | $ | 0.71 | $ | 0.41 |
6.
|
Revolving
Credit Facility
|
7.
|
Major
Supplier
|
8.
|
Employee
Stock Compensation
|
|
The
Company’s Director’s Plan permits the grant of share options and shares to
its Directors for up to 60,000 shares of common stock as stock
compensation in the aggregate. All stock options under this
Plan are granted at the fair market value of the common stock at the grant
date. This date is fixed only once a year upon a Board Member’s
re-election to the Board at the Annual Shareholders’ meeting which is the
third Wednesday in June pursuant to the Director’s Plan and our Company
By-Laws. Directors’ stock options vest ratably over a 6 month
period and generally expire 6 years from the grant
date.
|
|
The
following table represents our stock options granted, exercised, and
forfeited during the nine months ended October 31,
2008:
|
Stock
Options
|
Number
of
Shares
|
Weighted
Average
Exercise
Price per
Share
|
Weighted
Average
Remaining
Contractual
Term
|
Aggregate
Intrinsic
Value
|
|||||||||
Outstanding
at January 31, 2008
|
17,567 | $ | 13.48 |
2.65
years
|
$ | 8,618 | |||||||
Granted
in the nine months ended October 31, 2008
|
3,000 | $ | 13.10 |
5.89
years
|
----- | ||||||||
Outstanding
at October 31, 2008
|
20,567 | $ | 13.42 |
2.52
years
|
$ | 12,800 | |||||||
Exercisable
at October 31, 2008
|
17,567 | $ | 13.48 |
2.15
years
|
$ | 12,800 |
|
The
Company recognized total stock-based compensation costs of $226,540, of
which $194,996 results from the 2006 Equity Incentive Plan, and $31,544
results from the Non-Employee Directors Option Plan for the nine months
ended October 31, 2008 and $170,772 and $0 for the nine months ended
October 31, 2007, respectively. These amounts are reflected in
selling, general and administrative expenses. The total income
tax benefit recognized for stock-based compensation arrangements was
$81,554 and $61,478 for the nine months ended October 31, 2008 and 2007,
respectively.
|
Three
Months Ended
|
Nine
Months Ended
|
|||||||||||||||||||||||||||||||
October
31,
|
October
31,
|
|||||||||||||||||||||||||||||||
2008
|
2007
|
2008
|
2007
|
|||||||||||||||||||||||||||||
Domestic
|
$ | 18.8 | 75 | % | $ | 19.8 | 84.3 | % | $ | 61.3 | 77 | % | $ | 59.7 | 84.3 | % | ||||||||||||||||
International
|
$ | 6.4 | 25 | % | 3.7 | 15.7 | % | $ | 18.7 | 23 | % | 11.1 | 15.7 | % | ||||||||||||||||||
Total
|
$ | 25.2 | 100 | % | $ | 23.5 | 100 | % | $ | 80.0 | 100 | % | $ | 70.8 | 100 | % |
Three
Months Ended
October
31,
(in
millions of dollars)
|
Nine
Months Ended
October
31,
(in
millions of dollars)
|
|||||||||||||||
2008
|
2007
|
2008
|
2007
|
|||||||||||||
Net
Sales:
|
||||||||||||||||
North
America and other foreign
|
$ | 22.53 | $ | 23.62 | $ | 73.87 | $ | 72.67 | ||||||||
Brazil
|
2.44 | ----- | 5.52 | ----- | ||||||||||||
China
|
5.31 | 4.14 | 16.75 | 10.6 | ||||||||||||
India
|
.12 | .04 | .29 | .13 | ||||||||||||
Less
inter-segment sales
|
(5.25 | ) | (4.30 | ) | (16.42 | ) | (12.60 | ) | ||||||||
Consolidated
sales
|
$ | 25.16 | $ | 23.50 | $ | 80.00 | $ | 70.80 | ||||||||
Operating
Profit:
|
||||||||||||||||
North
America and other foreign
|
$ | 1.37 | $ | .62 | $ | 3.14 | $ | 1.87 | ||||||||
Brazil
|
.34 | ----- | 1.14 | ----- | ||||||||||||
China
|
.63 | 1.02 | 2.38 | 2.0 | ||||||||||||
India
|
(.22 | ) | (.22 | ) | (.63 | ) | (.46 | ) | ||||||||
Less
inter-segment profit
|
(.06 | ) | (.07 | ) | (.33 | ) | (.11 | ) | ||||||||
Consolidated
profit
|
$ | 2.06 | $ | 1.35 | $ | 5.70 | $ | 3.30 | ||||||||
Identifiable
Assets (at Balance Sheet date):
|
||||||||||||||||
North
America and other foreign
|
----- | ----- | $ | 79.57 | $ | 65.8 | ||||||||||
Brazil
|
----- | ----- | 6.63 | ----- | ||||||||||||
China
|
----- | ----- | 12.54 | 10.4 | ||||||||||||
India
|
----- | ----- | 4.38 | 4.3 | ||||||||||||
Consolidated
assets
|
----- | ----- | $ | 103.13 | $ | 80.5 | ||||||||||
Depreciation and
Amortization Expense:
|
||||||||||||||||
North
America and other foreign
|
$ | .14 | $ | .16 | $ | .64 | $ | .47 | ||||||||
Brazil
|
.11 | ----- | .11 | ----- | ||||||||||||
China
|
.07 | .07 | .21 | .27 | ||||||||||||
India
|
.09 | .08 | .27 | .08 | ||||||||||||
Consolidated
depreciation expense
|
$ | .41 | $ | .31 | $ | 1.23 | $ | .82 |
10.
|
Adoption
of FIN 48
|
11.
|
Related
Party Transactions
|
|
The
Company had no derivative instruments outstanding at October 31, 2008 for
foreign exchange. The Company had one derivative instrument
outstanding at October 31, 2007, which was treated as a cash flow hedge
intended for forecasted purchases of merchandise by the Company’s Canadian
subsidiary. The change in the fair market value of the effective
hedge portion of the foreign currency forward exchange contracts was
zero. During the nine month period ended October 31, 2008, the
Company recorded an immaterial loss in cost of goods sold for the
remaining portion of the foreign currency forward exchange contract that
did not qualify for hedge accounting treatment. The derivative
instrument was in the form of a foreign currency “participating forward”
exchange contract. The “participating forward” feature affords the Company
full protection on the downside and the ability to retain 50% of any
gains, in exchange for a premium at inception. Such premium is
built into the contract in the form of a different contract rate in the
amount of $0.016.
|
October
31, 2008
|
January
31, 2008
|
|||||||
Unrealized
Gains:
|
||||||||
Foreign
currency exchange contracts
|
----- | ----- | ||||||
Unrealized
(Losses):
|
||||||||
Foreign
currency exchange contracts
|
----- | $ | 77,000 | |||||
Interest
rate swaps
|
$ | 33,825 | ----- |
13.
|
Acquisition
of Qualytextil, SA and Increase in Revolving Credit
Line
|
Current
assets
|
($000
USD)
|
|||
Cash
and equivalents
|
$ | 34 | ||
Accounts
receivables
|
1,199 | |||
Inventory
|
3,309 | |||
Other
current assets
|
210 | |||
Total
current assets
|
4,752 | |||
Fixed
assets
|
1,249 | |||
Intangible
(Brands and Patents)
|
186 | |||
Other
non-current assets
|
606 | |||
Total
assets
|
6,791 | |||
Current
Liabilities
|
||||
Loans
|
3,093 | |||
Trade
payables and other current liabilities
|
3,477 | |||
Total
current liabilities
|
6,570 | |||
Other
non-current liabilities
|
82 | |||
Net
assets acquired
|
137 |
Total
cost of acquisition of Qualytextil, SA
|
$ | 13,670 | ||
Less
net assets acquired
|
(137 | ) | ||
Less
debt repayment at closing
|
(3,890 | ) | ||
Goodwill
at closing
|
9,643 | |||
FAS
52 foreign currency translation adjustment at October 31,
2008
|
(2,094 | ) | ||
Goodwill
at October 31, 2008 arising from Qualytextil, SA
|
$ | 7,549 |
Q1
FY
09
|
Q2
FY
09
|
Q3
FY
09
|
Q3
FY
09
YTD
|
Q1
FY
08
|
Q2
FY
08
|
Q3
FY
08
|
Q3
FY
08
YTD
|
|||||||||||||||||||||||||
Sales
|
$ | 29,245 | $ | 27,565 | $ | 25,160 | $ | 81,970 | $ | 27,112 | $ | 23,519 | $ | 26,411 | $ | 77,042 | ||||||||||||||||
Net
Income
|
1,158 | 1,625 | 1,373 | 4,156 | 580 | 934 | 1,559 | 3,073 | ||||||||||||||||||||||||
EPS
|
$ | 0.21 | $ | 0.30 | $ | 0.25 | $ | 0.76 | $ | 0.11 | $ | 0.17 | $ | 0.28 | $ | 0.56 |
Item
2.
|
Management’s
Discussion and Analysis of Financial Condition and Results
of Operations
|
|
·
|
$0.86
million operating expenses incurred by Qualytextil S.A., in Brazil now
included in the three months ended October 31, 2008, not previously
included.
|
|
·
|
$0.10
million increase in sales travel, trade shows and administrative travel
costs to Brazil.
|
|
·
|
$0.05
million higher freight out costs resulting from prevailing carrier rates
exclusive of Brazil.
|
|
·
|
($0.07)
million reduced R&D costs reflecting the completion of R&D on the
ChemMax product line in the prior
year.
|
|
·
|
($0.08)
million reduced operating expenses in
India.
|
|
·
|
($0.10)
million miscellaneous net
decreases.
|
|
·
|
$1.78
million operating expenses incurred by Qualytextil SA, in Brazil now
included in the nine months ended October 31,
2008.
|
|
·
|
$0.59
million additional freight out costs resulting from significantly higher
prevailing carrier rates and higher
volume.
|
|
·
|
$0.41
million in additional selling expenses, travel and commission exclusive of
Brazil.
|
|
·
|
$0.30
million in costs relating to the proxy
contest.
|
|
·
|
$0.28
million increased operating costs in China as the result of the large
increase included in direct international sales made by China, are now
allocated to SGA costs, previously allocated to cost of goods
sold.
|
|
·
|
$0.16
million higher operating expenses in Chile due to higher
volume.
|
|
·
|
$0.14
million miscellaneous increases.
|
|
·
|
($0.12)
million lower start-up expenses in
India.
|
|
·
|
($0.15)
million in reduced currency fluctuation
costs.
|
|
The
Company had one derivative instrument outstanding at October 31, 2007
which was treated as a cash flow hedge intended for forecasted purchases
of merchandise by the Company’s Canadian subsidiary no longer outstanding
at October 31, 2008. The change in the fair market value of the
effective hedge portion of the foreign currency forward exchange contracts
was a loss of $77,000, for the nine month period ended October
31, 2008 which was released into operations based on the timing of the
sales of the underlying inventory. The release to operations was
reflected in cost of products sold. During the period ended October
31, 2007, the Company recorded an immaterial loss in cost of goods sold
for the remaining portion of the foreign currency forward exchange
contract that did not qualify for hedge accounting
treatment. The derivative instrument was in the form of a
foreign currency “participating forward” exchange contract. The
“participating forward” feature affords the Company full protection on the
downside and the ability to retain 50% of any gains, in exchange for a
premium at inception. Such premium is built into the contract
in the form of a different contract rate in the amount of
$0.016.
|
October
31, 2008
|
January
31, 2008
|
|||||||
Unrealized
Gains:
|
||||||||
Foreign
currency exchange contracts
|
----- | ----- | ||||||
Unrealized
(Losses):
|
||||||||
Foreign
currency exchange contracts
|
----- | $ | 77,000 | |||||
Interest
rate swaps
|
$ | 33,825 | $ | 0 |
Item
3.
|
Quantitative and Qualitative Disclosures About Market
Risk
|
Item
4.
|
Controls
and Procedures
|
Item
4.
|
None
|
Item 6.
|
Exhibits and
Reports on Form 8-K:
|
Exhibits:
|
||
a.
|
31.1
Certification Pursuant to Rule 13a-14(b) and Rule 15d-14(b) of the
Exchange Act, Signed by Chief Executive Officer (filed
herewith)
|
|
b.
|
31.2
Certification Pursuant to Rule 13a-14(b) and Rule 15d-14(b) of the
Exchange Act, Signed by Chief Financial Officer (filed
herewith)
|
|
c.
|
32.1
Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002, Signed by Chief Executive
Officer (filed herewith)
|
|
d.
|
32.1
Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002, Signed by Chief Financial
Officer (filed herewith)
|
Reports
on Form 8-K:
|
|
a
-
|
On
August 1, 2008, the Company filed a Form 8-K under item 8.01 stating that
on July 23, 2008, the Company reached a settlement with the Internal
Revenue Service regarding its examination of the Company’s Federal Income
Tax returns for taxable years ending January 31, 2003, 2004 and
2005.
|
b
-
|
On
August 7, 2008, the Company filed a Form 8-K/A under items 5.03 and 8.01.
Item 5.03 states that on June 18, 2008 the Board of Directs of the Company
amended and restated the Bylaws of the Company. Item 8.01 states that on
June 18, 2008 the Board of Directors of the Company adopted various
amendments to the Bylaws.
|
c
-
|
On
September 9, 2008, the Company filed a Form 8-K under items 2.02 for the
purpose of furnishing a press release announcing the Company's Q2 FY09
financial results for the reporting period ended July 31,
2008.
|
d
-
|
On
September 23, 2008, the Company filed a Form 8-K under items 1.01 and
2.03. Item 1.01 states that on September 23, 2008 the Company entered into
an interest rate swap agreement with Wachovia Bank, N.A. pursuant to a
confirmation that incorporates the 1992 ISDA master Agreement, as amended
in 2006. Item 2.03 states Creation of a direct financial obligation or an
obligation under an off-balance sheet arrangement of a
registrant.
|
LAKELAND INDUSTRIES,
INC.
|
|
(Registrant)
|
|
Date: December
10, 2008
|
/s/ Christopher J.
Ryan
|
Christopher
J. Ryan,
|
|
Chief
Executive Officer, President,
|
|
Secretary
and General Counsel
|
|
(Principal
Executive Officer and Authorized
|
|
Signatory)
|
|
Date:
December 10, 2008
|
/s/Gary
Pokrassa
|
Gary
Pokrassa,
|
|
Chief
Financial Officer
|
|
(Principal
Accounting Officer and Authorized
|
|
Signatory)
|